TREATMENT OF RIGHT-SIDED STAPHYLOCOCCUS AUREUS ENDOCARDITIS IN INTRAVENOUS DRUG USERS WITH CIPROFLOXACIN AND RIFAMPICIN
The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
A combination of ciprofloxacin (intravenous then oral) and oral rifampicin was tested in 14 intravenous drug users with right-sided Staphylococcus aureus endocarditis. All 10 patients who completed therapy were cured based on resolution of symptoms and negative blood cultures at 4 weeks post therapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In each study, including one in which >70% of patients were HIV seropositive, 150 cure rates were >90%.”
In the citing paper
“Two studies have evaluated the use of predominantly oral 4-week antibiotic regimens (featuring ciprofloxacin plus rifampin) for the therapy of uncomplicated right-sided MSSA IE in IDUs.150,151”
Citations
Cites
Chambers, H. F., Miller, R. T., & Newman, M. D. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-109-8-619 · Cited by 214
Self-citationInfective endocarditis in heroin addicts
Banks, T., Fletcher, R. D., & Ali, N. (1973) · The American Journal of Medicine · doi:10.1016/0002-9343(73)90201-5 · Cited by 156
Staphylococcus aureus Endocarditis: Clinical Manifestations in Addicts and Nonaddicts
CHAMBERS, H. F., KORZENIOWSKI, O. M., & SANDE, M. A. (1983) · Medicine · doi:10.1097/00005792-198305000-00004 · Cited by 153
Self-citationFavorable Experience with Bacterial Endocarditis in Heroin Addicts
MENDA, K. B., & GORBACH, S. L. (1973) · Annals of Internal Medicine · doi:10.7326/0003-4819-78-1-25 · Cited by 140
Single or Combination Therapy of Staphylococcal Endocarditis in Intravenous Drug Abusers
ABRAMS, B., SKLAVER, A., HOFFMAN, T., & GREENMAN, R. (1979) · Annals of Internal Medicine · doi:10.7326/0003-4819-90-5-789 · Cited by 125
Hackbarth, C. J., Chambers, H. F., & Sande, M. A. (1986) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.29.4.611 · Cited by 90
Self-citationStaphylococcal Endocarditis in Drug Users: Clinical and Microbiologic Aspects
Tuazon, C. U., Cardella, T. A., & Sheagren, J. N. (1975) · Archives of Internal Medicine · doi:10.1001/archinte.135.12.1555 · Cited by 75
Intravenous Followed by Oral Antimicrobial Therapy for Staphylococcal Endocarditis
PARKER, R. H., & FOSSIECK, B. E. (1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-6-832 · Cited by 62
Staphylococcal Endocarditis in Addicts
Sklaver, A. R., Hoffman, T. A., & Greenman, R. L. (1978) · Southern Medical Journal · doi:10.1097/00007611-197806000-00009 · Cited by 43
Carpenter, T. C., Hackbarth, C. J., Chambers, H. F. “., & Sande, M. A. (1986) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.30.3.382 · Cited by 33
Self-citation
Cited by
Staphylococcus aureus Infections
Lowy, F. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808203390806 · Cited by 6,005
Liu, C., Bayer, A., Cosgrove, S. E., Daum, R. S., Fridkin, S. K., Gorwitz, R. J., Kaplan, S. L., Karchmer, A. W., Levine, D. P., Murray, B. E., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq146 · Cited by 4,191
“limited data on the use of oral ciprofloxacin in combination with oral rifampin primarily in patients with MSSA right-sided endocarditis [189, 190].”
Self-citationBaddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Tleyjeh, I. M., Rybak, M. J., Barsic, B., Lockhart, P. B., Gewitz, M. H., Levison, M. E., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000296 · Cited by 3,232
“Enterococci are the third leading cause of IE and account for ≈10% of cases in nonIDUs.”
BackgroundInfluentialBaddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Bolger, A. F., Levison, M. E., Ferrieri, P., Gerber, M. A., Tani, L. Y., Gewitz, M. H., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.165564 · Cited by 1,707
Guidelines for the management of intravascular catheter-related infections
Mermel, L. A., Farr, B. M., Sherertz, R. J., Raad, I. I., O'Grady, N., Harris, J. S., & Craven, D. E. (2001) · Clinical Infectious Diseases · doi:10.1086/320001 · Cited by 1,449
“aureus [180, 181].”
Metadata
- Authors
- Dworkin, R. J., Sande, M. A., Lee, B. L., & Chambers, H. F.
- Affiliations
- San Francisco General Hospital (US)
- ORCID
- Chambers, H.F.
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 1989-11
- Volume
- 334
- Issue
- 8671
- Pages
- 1071-1073
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2028302215
- Cited by
- 170
- References
- 10
- Citations by year
- 2025: 3 · 2024: 1 · 2023: 7 · 2022: 5 · 2021: 3 · 2020: 10 · 2019: 7 · 2018: 3 · 2017: 1 · 2016: 3 · 2015: 6 · 2014: 3 · 2013: 3
- FWCI
- 5.93
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- The Lancet (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Health Sciences › Medicine › Infectious Diseases › Streptococcal Infections and Treatments
- Keywords
- Staphylococcus aureus endocarditis, right-sided endocarditis, people who inject drugs, ciprofloxacin, rifampicin, combination antibiotic therapy, intravenous drug use
- MeSH terms
- Adult, Ciprofloxacin, Drug Administration Schedule, Drug Therapy, Combination, Echocardiography, Endocarditis, Bacterial, Female, Follow-Up Studies, Humans, Male, Pilot Projects, Rifampin, Staphylococcal Infections, Substance Abuse, Intravenous
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: TREATMENT OF RIGHT-SIDED STAPHYLOCOCCUS AUREUS ENDOCARDITIS IN INTRAVENOUS DRUG USERS WITH CIPROFLOXACIN AND RIFAMPICIN. https://app.cochat.ai/papers/10.1016/s0140-6736(89)91083-0
- The paper
- Dworkin, R. J., Sande, M. A., Lee, B. L., & Chambers, H. F. (1989). TREATMENT OF RIGHT-SIDED STAPHYLOCOCCUS AUREUS ENDOCARDITIS IN INTRAVENOUS DRUG USERS WITH CIPROFLOXACIN AND RIFAMPICIN. The Lancet. https://doi.org/10.1016/s0140-6736(89)91083-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.